Prehypertension and cardiovascular risk factors in adults enrolled in a primary care programme

European Journal of Preventive Cardiology

Volumn 18, Issue 2, 2011, Pages 233-239

  Nery, Aline B ^a   Mesquita, Evandro T ^a   Lugon, Jocemir R ^a   Kang, Hye Chung ^a   de Miranda, Veronica A ^b   de Souza, Bernardo Gt ^a   Andrade, Juliana Am ^a   Rosa, Maria Luiza G ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b County Health Foundation ^*  (Brazil)

Author keywords

obesity; Prehypertension; risk factors

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; SODIUM CHLORIDE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; DIABETES MELLITUS; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PREHYPERTENSION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SEX DIFFERENCE;

ADULT; ALCOHOL DRINKING; BIOLOGICAL MARKERS; BODY MASS INDEX; BRAZIL; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERURICEMIA; LIPIDS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PREHYPERTENSION; PRIMARY HEALTH CARE; RISK ASSESSMENT; RISK FACTORS; SMOKING; URIC ACID; YOUNG ADULT;

EID: 79959191367     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/1741826710389380     Document Type: Article

References (28)

1. Lawes C, Hoorn S, Law M, Elliot P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens 2006; 24(3): 423–430.
2. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903–1913.
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–1252.
4. Agyemang C, van Valkengoed I, van den Born BJ, Stronks K. Prevalence and determinants of prehypertension among African Surinamese, Hindustani Surinamese, and White Dutch in Amsterdam, the Netherlands: the SUNSET study. Eur J Cardiovasc Prev Rehabil 2007; 14: 775–781.
5. Ferguson TS, Younger NO, Tulloch-Reid MK, Wright MB, Ward EM, Ashley DE, et al. Prevalence of prehypertension and its relationship to risk factors for cardiovascular disease in Jamaica: analysis from a cross-sectional survey. BMC Cardiovasc Disord 2008; 28: 8–20.
6. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999–2000. Arch Intern Med 2004; 164: 2113–2118.
7. Zheng L, Sun Z, Zhang X, Xu C, Li J, Hu D, Sun Y. Predictors of progression from prehypertension to hypertension among rural Chinese adults: results from Liaoning Province. Eur J Cardiovasc Prev Rehabil. 2010; 17: 217–222.
8. Bowman TS, Sesso HD, Glynn RJ, Gaziano JM. JNC 7 category and risk of cardiovascular death in men: are there differences by age? Am J Geriatr Cardiol 2005; 14: 126–131.
9. Vasan RS, Larson MG, Leip EP, Evans JC, O’Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291–1297.
10. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005; 111: 697–716.
11. Salles-Costa R, Werneck GL, Lopes CL, Faerstein E. Associação entre fatores sócio-demográficos e prática de atividade física de lazer no Estudo Pró-Saúde. Cadernos de Saúde Pública 2003; 19: 1095–1105.
12. Chor D. Perfil de risco cardiovascular de funcionários de banco estatal [tese doutorado]. São Paulo: Universidade de São Paulo, 1997.
13. Sichieri R, Everhart JE. Validity of a Brazilian food frequency questionnaire against dietary recalls and estimated energy intake. Nutrition Research 1998; 18: 1649–1659.
14. Nettleton JA, Schulze MB, Jiang R, Jenny NS, Burke GL, Jacobs DR Jr. A priori–defined dietary patterns and markers of cardiovascular disease risk in the Multi-Ethnic Study of Atherosclerosis (MESA). American Journal of Clinical Nutrition 2008; 88: 185–194.
15. Ganguly SS, Al-Shafaee MA, Bhargava K, Duttagupta KK. Prevalence of prehypertension and associated cardiovascular risk profiles among prediabetic Omani adults. BMC Public Health 2008; 8: 108–108.
16. Toprak A, Wang H, Chen W, Paul T, Ruan L, Srinivasan S, et al. Prehypertension and black-white contrasts in cardiovascular risk in young adults: Bogalusa Heart Study. J Hypertens 2009; 27: 243–250.
17. Lee J, Heng D, Ma S, Chew SK, Hughes K, Tai ES, Influence of prehypertension on all-cause and cardiovascular mortality: the Singapore Cardiovascular Cohort Study. Int J Cardiol 2009; 10135: 331–337.
18. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001; 344: 3–10.
19. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336: 1117–1124.
20. Ashley FW Jr, Kannel WB. Relation of weight change to changes in atherogenic traits: Framinghan Study. J Chronica Dis 1974; 27: 103–104.
21. Stevens VJ, Corrigan SA, Obarzanek E, Bernauer E, Cook NR, Hebert P, et al. Weight loss Intervention in phase 1 of the trials of hypertension prevention. Arch Intern Med 1993; 153(7): 849–858.
22. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005; 45: 9–14.
23. Redon J, Cifkova R, Laurent S, Nilsson P, Narkiewicz K, Erdine S, et al. Mechanisms of hypertension in the cardiometabolic syndrome. J Hypertens 2009; 27: 441–451.
24. Liang J, Xue Y, Zou C, Zhang T, Song H, Qi L. Serum uric acid and prehypertension among Chinese adults. J Hypertens 2009; 27: 1761–1765.
25. Syamala S, Li J, Shankar A. Association between serum uric acid and prehypertension among US adults. J Hypertens 2007; 25: 1583–1589.
26. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67: 1739–1742.
27. Feig DI, Nakagawa T, Karumanchi SA, Oliver WJ, Kang DH, Finch J, et al. Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int 2004; 66: 281–287.
28. Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 2008; 26: 269–275.